載入...
Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies
BACKGROUND: The PROTECT‐AF (Watchman Left Atrial Appendage Closure Technology for Embolic Protection in Patients With Atrial Fibrillation) and PREVAIL (Evaluation of the Watchman LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy) trials demonstrated noninferio...
Na minha lista:
| 發表在: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6912972/ https://ncbi.nlm.nih.gov/pubmed/31752643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.013525 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|